down arrow

Orchid Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE191A01027
  • NSEID: ORCHPHARMA
  • BSEID: 524372
INR
727.95
22.95 (3.26%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 43.35 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Sep'08
Net Sales
467.10
381.68
296.24
220.05
227.72
267.05
666.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
32.47
Total Operating income
467.10
381.68
296.24
220.05
227.72
267.05
699.33
Raw Material Cost
306.49
236.27
225.13
160.51
126.09
124.04
351.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.06
21.55
(Increase) / Decrease In Stocks
-25.08
-1.87
-55.01
-41.36
-35.50
-2.40
-104.13
Employee Cost
42.06
33.78
32.31
31.72
38.03
42.73
64.23
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
174.40
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
80.80
68.04
63.54
58.30
61.86
115.76
-0.00
Total Expenditure (Excl Depreciation)
404.27
336.22
265.97
209.17
190.48
280.19
507.90
Operating Profit (PBDIT) excl Other Income
62.83
45.46
30.27
10.88
37.24
-13.14
191.43
Other Income
15.09
10.24
8.77
4.89
2.20
11.77
0.02
Operating Profit (PBDIT)
77.92
55.70
39.04
15.77
39.44
-1.37
191.45
Interest
6.83
9.35
17.06
20.77
26.92
0.09
61.82
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-140.38
Gross Profit (PBDT)
71.09
46.35
21.98
-5.00
12.52
-1.46
-10.75
Depreciation
17.07
15.55
39.39
40.18
59.60
63.07
66.18
Profit Before Tax
54.02
30.80
-17.41
-45.19
-47.08
-64.52
-76.92
Tax
-0.15
0.00
0.00
0.00
0.00
0.00
-5.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
54.17
30.80
-17.41
-45.19
-47.08
-64.52
-71.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
63.68
0.00
0.00
0.00
Net Profit
54.17
30.80
-17.41
18.50
-47.08
-64.52
-71.80
Share in Profit of Associates
2.41
-1.59
-3.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
56.59
29.21
-20.41
18.50
-47.08
-64.52
-71.80
Equity Capital
50.72
50.72
40.82
40.82
40.82
88.96
70.44
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
11.16
5.76
-5.0
4.53
-11.53
-7.25
-10.19
Diluted Earnings per share
11.16
6.35
-5.0
4.53
-11.53
-7.25
-10.47
Operating Profit Margin (Excl OI)
13.45%
11.91%
10.22%
4.94%
16.35%
-4.92%
27.37%
Gross Profit Margin
15.22%
12.14%
7.42%
-2.27%
5.5%
-0.55%
-1.54%
PAT Margin
11.6%
8.07%
-5.88%
-20.54%
-20.67%
-24.16%
-10.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 22.38% vs 28.84% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 93.74% vs 243.12% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 38.21% vs 50.18% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is -26.95% vs -45.19% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has improved from Sep 2023

Compare Half Yearly Results Of Orchid Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
467.10
5,969.93
-5,502.83
-92.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
467.10
5,969.93
-5,502.83
-92.18%
Raw Material Cost
306.49
934.97
-628.48
-67.22%
Purchase of Finished goods
0.00
857.27
-857.27
-100.00%
(Increase) / Decrease In Stocks
-25.08
-104.82
79.74
76.07%
Employee Cost
42.06
1,280.21
-1,238.15
-96.71%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
80.80
1,470.50
-1,389.70
-94.51%
Total Expenditure (Excl Depreciation)
404.27
4,438.13
-4,033.86
-90.89%
Operating Profit (PBDIT) excl Other Income
62.83
1,531.80
-1,468.97
-95.90%
Other Income
15.09
210.03
-194.94
-92.82%
Operating Profit (PBDIT)
77.92
1,741.83
-1,663.91
-95.53%
Interest
6.83
18.01
-11.18
-62.08%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
71.09
1,723.82
-1,652.73
-95.88%
Depreciation
17.07
213.36
-196.29
-92.00%
Profit Before Tax
54.02
1,510.46
-1,456.44
-96.42%
Tax
-0.15
314.99
-315.14
-100.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
54.17
1,195.47
-1,141.30
-95.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
54.17
1,195.47
-1,141.30
-95.47%
Share in Profit of Associates
2.41
6.48
-4.07
-62.81%
Minority Interest
0.00
-11.99
11.99
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
56.59
1,189.96
-1,133.37
-95.24%
Equity Capital
50.72
40.06
10.66
26.61%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
11.16
29.70
-18.54
-62.42%
Diluted Earnings per share
11.16
29.65
-18.49
-62.36%
Operating Profit Margin (Excl OI)
13.45%
25.66%
0.00
-12.21%
Gross Profit Margin
15.22%
28.88%
0.00
-13.66%
PAT Margin
11.60%
20.13%
0.00
-8.53%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 467.10 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 22.38% vs 28.84% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 56.59 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 93.74% vs 243.12% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.83 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 38.21% vs 50.18% in Sep 2023

Half Yearly - Interest
Interest 6.83 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -26.95% vs -45.19% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.45%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has improved from Sep 2023